story of the week
Novel CD19 CAR T Cells Manufactured Next Day for Acute Lymphoblastic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Cancer Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia
Blood Cancer J 2022 Jun 24;12(6)96, C Zhang, J He, L Liu, J Wang, S Wang, L Liu, J Ge, L Gao, L Gao, P Kong, Y Liu, J Liu, Y Han, Y Zhang, Z Sun, X Ye, W Yin, M Sersch, L Shen, WW Cao, X ZhangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.